Skip to main content
Equibles
VRTX logo

VRTX · Vertex Pharmaceuticals Inc · Held by Funds

Track VRTX — free

Use VRTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VRTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$538.60 -4.02 (-0.74%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
S&P 500 member Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$136.56B
Shares
253.54M
Volume · Nov 13 757.93K Avg daily vol (3M) 1.24M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of VRTX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 18.29% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 4.28% 10,851,387
Index ETFs 14.01% 35,532,121
Active ETFs 2.09% 5,299,506
Active funds 20.14% 51,058,721
Unclassified 8.62% 21,843,364
All registered funds 49.14% 124,585,099
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding VRTX

1,185 fund positions
Fund Balance Value % of Fund Open
Growth Fund of America 12,908,237 $7,028,793,211 1.99%
VANGUARD TOTAL STOCK MARKET INDEX FUND 8,058,128 $4,002,713,921 0.17%
VANGUARD 500 INDEX FUND 6,576,510 $3,266,749,812 0.20%
Investment Co of America 6,269,142 $3,114,070,906 1.69%
American Balanced Fund 5,558,357 $2,761,002,673 0.96%
Invesco QQQ Trust, Series 1 5,387,574 $2,676,169,633 0.55%
AMCAP Fund 4,734,921 $2,578,259,183 2.73%
Fidelity 500 Index Fund 3,294,618 $1,793,985,393 0.21%
iShares Core S&P 500 ETF 3,491,802 $1,734,482,807 0.20%
New Perspective Fund 3,366,011 $1,671,998,644 0.98%
State Street(R) SPDR(R) S&P 500(R) ETF Trust 3,075,882 $1,527,882,866 0.20%
VANGUARD GROWTH INDEX FUND 2,784,526 $1,383,157,600 0.36%
Capital World Growth & Income Fund 2,377,362 $1,294,521,156 0.82%
Washington Mutual Investors Fund 1,975,814 $942,660,859 0.43%
VANGUARD HEALTH CARE FUND 1,890,142 $901,786,748 2.36%
State Street(R) Health Care Select Sector SPDR(R) ETF 1,793,091 $890,682,092 2.19%
New Economy Fund 1,618,634 $881,378,586 1.76%
Growth Fund 1,640,858 $815,063,394 1.42%
Putnam Large Cap Value Fund 1,667,112 $795,379,135 1.44%
iShares Biotechnology ETF 1,478,300 $734,315,959 8.08%
Growth-Income Fund 1,464,610 $727,515,725 1.58%
VANGUARD INSTITUTIONAL INDEX FUND 1,377,846 $684,417,444 0.20%
JPMorgan Equity Premium Income ETF 1,319,151 $655,261,876 1.46%
Invesco NASDAQ 100 ETF 1,165,082 $634,410,451 0.61%
American Funds Fundamental Investors 1,173,690 $583,007,034 0.32%
Capital Group Growth ETF 945,914 $515,069,091 2.03%
Loomis Sayles Growth Fund 1,025,313 $509,303,726 3.10%
VANGUARD HEALTH CARE INDEX FUND 776,632 $422,891,657 1.92%
American Funds Global Balanced Fund 781,621 $372,911,379 1.11%
iShares MSCI USA Min Vol Factor ETF 722,470 $344,690,437 1.46%
Harbor Capital Appreciation Fund 705,868 $336,769,623 1.35%
Schwab U.S. Large-Cap Growth ETF 616,442 $335,664,998 0.53%
Asset Allocation Fund 653,520 $324,622,990 1.15%
Capital Group Dividend Value ETF 559,392 $304,600,132 0.79%
State Street(R) SPDR(R) Portfolio S&P 500(R) ETF 605,056 $300,549,467 0.20%
Putnam Focused Large Cap Value ETF 535,636 $291,664,515 2.07%
iShares Russell 1000 Value ETF 567,848 $282,067,137 0.35%
T. Rowe Price Health Sciences Fund, Inc. 548,135 $272,275,099 2.28%
Schwab S&P 500 Index Fund 566,940 $270,487,074 0.19%
Columbia Contrarian Core Fund 490,329 $266,993,947 1.44%
Fidelity Total Market Index Fund 484,773 $263,968,594 0.19%
JPMorgan U.S. Equity Fund 502,245 $249,480,159 0.75%
AB LARGE CAP GROWTH FUND INC 486,048 $241,434,623 1.06%
JPMorgan Nasdaq Equity Premium Income ETF 483,197 $240,018,446 0.59%
Strategic Advisers U.S. Total Stock Fund 417,098 $227,118,203 0.23%
Capital Group Core Equity ETF 412,965 $224,867,702 1.90%
Fidelity Series Total Market Index Fund 395,792 $215,516,660 0.19%
BlackRock Health Sciences Opportunities Portfolio 390,198 $212,470,615 3.33%
Victory Pioneer Fund 422,068 $209,653,838 1.87%
VANGUARD U.S. GROWTH FUND 383,653 $208,906,732 0.47%
Showing 1–50 of 1,185 positions
Key facts CIK 875320 CUSIP 92532F100 13F (30d) 1437 filings 1358 filers Visit website Investor relations